OTCM
DNMR
Market cap1mUSD
Nov 03, Last price
0.35USD
Name
Danimer Scientific Inc
Chart & Performance
P/E
—
P/S
0.02
EPS
—
Div Yield, %
—
Shrs. gr., 5y
103.00%
Rev. gr., 5y
8.92%
Revenues
47m
-12.28%
Net income
-155m
L-13.51%
CFO
-47m
L-23.57%
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Danimer Scientific, Inc. is an innovative polymer firm specializing in the creation, manufacturing, and supply of eco-friendly bioplastics designed to replace conventional oil-derived plastics. Among its key offerings is polyhydroxyalkanoate (PHA), a fully biodegradable plastic raw material sold under the Nodax brand. This versatile substance finds applications in diverse plastic products such as films, drinking straws, food packaging, and various other items. The company also develops polylactic acid (PLA) based resins specifically formulated for coating single-use paper cups, alongside a portfolio of other sustainable biopolymer solutions. Its biopolymer products are available in multiple forms, including additives, water-based coatings, fibers, filaments, films, and materials suitable for thermoforming and injection molding processes. Danimer Scientific targets its sales efforts towards brand owners in consumer packaging, plastic converters, and various manufacturers within the broader plastics sector. Established in 2004, Danimer Scientific, Inc. operates from its headquarters in Bainbridge, Georgia.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|
| 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | |
| Income | ||||||
Revenues | ||||||
Cost of revenue | ||||||
Unusual Expense (Income) | ||||||
NOPBT | ||||||
NOPBT Margin | ||||||
Operating Taxes | ||||||
Tax Rate | ||||||
NOPAT | ||||||
Net income | ||||||
Dividends | ||||||
Dividend yield | ||||||
Proceeds from repurchase of equity | ||||||
BB yield | ||||||
| Debt | ||||||
Debt current | ||||||
Long-term debt | ||||||
Deferred revenue | ||||||
Other long-term liabilities | ||||||
Net debt | ||||||
| Cash flow | ||||||
Cash from operating activities | ||||||
CAPEX | ||||||
Cash from investing activities | ||||||
Cash from financing activities | ||||||
FCF | ||||||
| Balance | ||||||
Cash | ||||||
Long term investments | ||||||
Excess cash | ||||||
Stockholders' equity | ||||||
Invested Capital | ||||||
ROIC | ||||||
ROCE | ||||||
| EV | ||||||
Common stock shares outstanding | ||||||
Price | ||||||
Market cap | ||||||
EV | ||||||
EBITDA | ||||||
EV/EBITDA | ||||||
Interest | ||||||
Interest/NOPBT | ||||||